Although the first in-situ hybridization (ISH) experiments were performed more than two decades ago, it was not until 1987 that the technique was implemented in the study of preimplantation. Since then, several groups have explored the feasibility of using the ISH technique as a diagnostic tool to study the genomic constitution of human preimplantation embryos. Though a fair number of such ISH studies have been published and unravelling of the embryos' genomic secrets proceeds with great strides, there are still many challenges in this area of research. The scope of this review is to outline the research and diagnostic applications of single and multicolour (fluorescence) ISH to study the chromosomal content of human preimplantation embryos and to discuss the implications for human preimplantation genetic diagnosis. Current hybridization techniques are being discussed, including the capabilities and pitfalls of this approach when applied to human preimplantation embryos. Finally, future perspectives for the ISH technique in studying the genomic constitution of preimplantation embryos are reviewed.
Introduction
The introduction of in-vitro fertilization (IVF) treatment has created the possibility of investigating human gametes and zygotes. The confluence of evolving assisted reproductive technologies and the development of highly specific molecular and genetic techniques allows the investigation of embryos at the earliest stages of development for the presence of disease-related chromosomal changes. By such means, preimplantation genetic diagnosis (PGD) of inherited disease offers selective transfer of unaffected embryos. PGD thus offers new perspectives to couples at risk of transmitting inheritable disease to their offspring (Edwards and Hollands, 1988; Snowdon and Green, 1997) .
PGD can be performed preconceptionally or at early preimplantation embryonic stages and requires access to gametes (unfertilized oocytes) or cleaving (pre-)embryos, respectively. Moreover, efficient and safe biopsy methods as well as sensitive and reliable procedures to analyse the genomic constitution of single or few cells are needed. Inherited diseases are caused by a number of genetic aberrations, ranging from numerical chromosomal abnormalities to single gene defects. Molecular techniques, such as (fluorescence) in-situ hybridization [(F)ISH] and the polymerase chain reaction (PCR) can be applied to examine genetic material for the presence of such aberrations.
Practical aspects of preimplantation genetic diagnosis
The DNA material needed for PGD is obtained by biopsy procedures (Tarin and Handyside, 1993) . The two most commonly used approaches are removal of the first (Verlinsky et al., 1992) or first and second polar body (Rechitsky et al., 1996a) from the unfertilized oocyte and removal of one or more blastomeres from a cleavage stage embryo . Multiple oocytes are obtained through ovulation induction and may be fertilized and cultured in vitro in order to obtain cleavage stage embryos. Biopsy of cleavage stage embryos is usually performed 3 days after IVF when the embryo is at the 4-10-cell stage, allowing the analysis of one or two blastomeres. A third alternative for obtaining embryonic material is the removal of trophectoderm cells at the blastocyst stage (Dokras et al., 1990) . Removal of the first polar body and its subsequent analysis yields only information on aberrations present in the maternal genome and could suffer from a false diagnosis due to recombination of homologous chromosomes before extrusion of the second polar body. The same holds true for errors due to non-disjunction at meiosis I (Angell et al., 1991; Angell, 1994) . Of the three methods mentioned above, biopsy of cleavage stage human embryos is the procedure most widely used. Studies by Tarin et al. (1992) suggested that reduction of blastomere number by biopsy at day 2 (2-4-cell stage) reduces the inner cell mass (ICM) at later stages of development, indicating that the quality of the embryo might be affected. Preimplantation development seems not to be adversely affected when blastomere biopsy is performed on day 3 Soussis et al., 1996a,b) and pregnancy rates following embryo transfer are within the normal range (Handyside et al., 1990) . Micromanipulation of day 3 preimplantation embryos does not cause impaired embryonic development and provides access to single blastomeres in a non-destructive fashion. Thereby, it allows genetic diagnosis of embryos prior to transfer and subsequent implantation. However, the time available and the amount of embryonic material obtainable for analyses are limited and place restrictions on the methods used. At the same time, the applied techniques have to comply with high standards (efficient and reliable), as a diagnosis must be made on basis of the analysis of only one or two cells. Biopsy of trophectoderm cells at the blastocyst stage offers the possibility of analysing multiple cells, without interfering with the integrity of the embryo proper. Unfortunately, only a relatively low percentage of embryos resulting from normal fertilization reaches the blastocyst stage in vitro (Hardy, 1991) , and at present it is not known whether the already differentiated trophoblast cells still fully represent the embryo proper (Benkhalifa et al., 1993) . Blastocysts can be recovered from the uterus by flushing the uterine cavity (Buster et al., 1985) . However, attempts to increase the number of blastocysts retrieved by uterine lavage after ovulation induction were not successful (Carson et al., 1991) . The use of co-culture systems (applying feeder layers), although not allowed in certain countries, might increase the proportion of blastocysts developing in vitro from the pronuclear stage (Bongso et al., 1991a) .
Attempts have been made to obtain multiple, undifferentiated embryonic cells for genetic analysis (Geber et al., 1995) . However, in-vitro proliferation of blastomeres biopsied from cleavage-stage embryos is rather inefficient and is, from a practical point of view, less applicable because of the time pressure encountered during a PGD procedure. Recently, a modified displacement technique, involving zona drilling and fluid displacement, was described as an alternative to current biopsy techniques (Pierce et al., 1997) .
Genetic defects to be analysed by preimplantation genetic diagnosis
PGD is primarily useful in examining embryos for the presence of DNA characteristics specific for inherited diseases with a high recurrence risk.
Structural aberrations
Structural aberrations, such as translocations and inversions, play a major role in the vast majority of cytogenetic abnormalities with a high recurrence risk. Couples in which one of the partners carries a balanced translocation, and which have a history of miscarriage with unbalanced chromosomal rearrangements, are known to be at risk of having another affected pregnancy. The actual recurrence risk depends on the chromosomes involved in the translocation, the location of the breakpoints and the sex of the translocation carrier and can vary between only 1 or 2% and 100% (in the case of Robertsonian translocations). PGD can select for normal or balanced embryos, thereby preventing transfer of affected, i.e. unbalanced, embryos.
Single gene defects
The risk of repetitious affected pregnancies associated with certain single gene defects, is often very high and is determined by the pattern of inheritance. Specific diagnosis is being attempted for prevalent gene defects, especially those caused by a predominant or a limited number of DNA mutations. PGD to investigate the presence of a gene mutation in an embryo allows selection of unaffected (wildtype or, in case of recessive disease, heterozygous) embryos for transfer.
Sex-linked diseases
Many recessive genetic disorders are X-linked and the chances of a normal male child are therefore theoretically 50%. However, a considerable number of these sex-linked pathological conditions are not well characterized or can be caused by too many DNA mutations and no specific methods for DNA diagnoses at the single cell level are available. Hence, indiscriminate termination of all male pregnancies remains the only option for couples at risk. Preimplantation sex diagnosis offers an alternative in the case of these X-linked diseases by selecting only female embryos for transfer. In the case of paternally inherited X-linked (dominant) disease, selection and subsequent transfer of male embryos is performed (Simpson et al., 1996) .
Aneuploidies
Chromosomal abnormalities, especially aneuploidies, are present in a considerable fraction of embryos. The most common abnormalities are made up by aneuploidy of the sex chromosomes and trisomies of the autosomes 13, 18 and 21. Together they comprise >95% of all numerical aberrations present in life born children. These aneuploidies are compatible with development to term only in a minority of cases but do cause congenital abnormalities of varying severity. Monosomies are generally lethal in early development (except in a few cases of Turner's syndrome 45,XO) but have been found in human preimplantation embryos Benadiva et al., 1996) . By performing PGD to determine the ploidy status of chromosomes often involved in aneuploidy, birth of affected offspring can be prevented. The majority of the mentioned aneuploidies arises de novo, in embryos from couples without previously known risk. Although it is unlikely that such couples will participate in a diagnostic programme, PGD to determine the copy number of certain chromosomes in first polar bodies or cleavage stage embryos could be of benefit to older women (>35 years), who are at increased risk of trisomies, probably due to non-disjunction at maternal meiosis I (Hassold et al., 1993; Munné et al., 1995a; Dailey et al., 1996; Dyban et al., 1996; Verlinsky et al., 1996a,b) . Preimplantation genetic screening (PGS) for aneuploidies in embryos of older women already undergoing infertility treatment (Munné et al., 1995b,c; Verlinsky et al., 1996b) , may in future become a major area of application for PGD.
Diagnostic methods in preimplantation genetic diagnosis

Biochemical assays
Genetic disease can be diagnosed either directly from the DNA or indirectly from the gene product. If this product is an enzyme, the secretion into the culture medium can be measured to provide information on the genotype of the embryo. Assays have been developed for measuring enzyme activity of mouse embryos at varying stages of development (Monk et al., 1987; Sermon et al., 1991) . However, attempts at implementing these technologies in a human embryo model have so far been unsuccessful (Braude, 1991; Sermon et al., 1992) . The human embryonic genome is activated relatively late, i.e. between the 4-and 8-cell stage (Braude et al., 1988) . Therefore, measurable enzyme activities in these early cleavage stages will predominantly be maternally derived and will obscure embryonic gene activity.
Karyotyping
For the detection of chromosomal abnormalities, cytogenetic analysis of banded metaphase chromosomes would be the method of choice. However, this procedure is time consuming, laborious and rather inefficient due to difficulties in obtaining adequate metaphase preparations. Furthermore, problems with chromosome spreading and banding, due to the compact nature of embryonic chromosomes, have so far prevented the development of reproducible procedures for a reliable karyotyping of human embryo nuclei (Santalo et al., 1995) .
Polymerase chain reaction
In PGD, PCR is mainly used for detection of single gene defects. The PCR procedure facilitates the in-vitro synthesis of multiple copies of a specific DNA fragment and has been shown to be sufficiently sensitive to permit the detection of unique DNA sequences from a single cell (Li et al., 1988) . DNA amplification from single cells has been achieved by developing sensitive, nested-primer strategies. Unfortunately, its powerful sensitivity based on DNA amplification is also one of the most significant limitations of the procedure: contaminating DNA sequences may be coamplified and contribute to a false diagnosis. A number of strategies have been reported to address this limitation (Kwok and Higuchi, 1989; Pickering et al., 1994) . A second problem in using the PCR method for single blastomere analyses is amplification failure, especially if a diagnosis is based on the absence of a signal after DNA amplification . Alternatively, simultaneous amplification of multiple DNA loci on the same or on different chromosomes (Strom et al., 1991; Chong et al., 1993) or application of random genomic DNA amplification methods preceding the specific PCR analyses (Gibbons et al., 1995; Sermon et al., 1996a) , may circumvent this problem and prevent false negative results. Other phenomena causing embryo genotype errors are the (unnoticed) presence of anuclear blastomeres (Liu et al., 1993) , preferential amplification, hypo-amplification of one allele, and allelic drop-out (ADO), total amplification failure of one allele (Findlay et al., 1995a) . Although the PCR method has been successfully applied to determine the sex of embryonic nuclei (Handyside et al., , 1990 Grifo et al., 1992; Liu et al., 1994) , its particular strength lies in the detection of single-gene defects causing diseases such as cystic fibrosis (Coutelle et al., 1989; Strom et al., 1990; Handyside et al., 1992; Liu et al., 1992 Liu et al., , 1993 Verlinsky et al., 1992; Wu et al., 1993; Avner et al., 1994; Ao et al., 1996a,b; Dreesen et al., 1996) , Duchenne/Becker muscular dystrophy (Holding et al., 1993; Kristjansson et al., 1994; Liu et al., 1995; Kang et al., 1996) , Tay-Sachs disease (Morsy et al., 1992; Sermon et al., 1995a,b) , sickle cell anaemia (Pickering et al., 1992; Sheardown et al., 1992; Muggleton-Harris et al., 1993) , β-thalassaemia (Holding and Monk, 1989; Varawalla et al., 1991) , LeschNyhan syndrome (Delhanty, 1994) , fragile-X syndrome (Levinson et al., 1994; Dreesen et al., 1995) , myotonic dystrophy (Sermon et al., 1996b) , Huntington disease (Schulman et al., 1996) and Marfan syndrome (Harton et al., 1996) . Furthermore, assays have been developed for single cell analysis of the RhD blood type (van den Veyver et al., 1995; Avner et al., 1996) . Recently, Findlay et al. (1995b Findlay et al. ( , 1996 described the simultaneous diagnosis of embryo sex and single gene defect status using a fluorescent PCR strategy. The most reliable technique for the detection of chromosomal abnormalities in preimplantation embryos is the ISH using DNA probes for identifying the genotype of human embryos (Jones et al., 1987; West et al., 1988) . The (F)ISH method permits analysis of both numerical and structural aberrations in metaphase chromosomes as well as in interphase nuclei (Lichter et al., 1991; Tkacuk et al., 1991) . In PGD, the FISH technique is mainly used for sex diagnosis and detection of structural chromosomal abnormalities. Although the information obtained by the use of (F)ISH is limited to the DNA targets examined, it has the advantage that virtually every nucleus in an embryo is informative , in contrast to conventional karyotyping. Furthermore, the (F)ISH procedure is not hampered by contamination, which is a distinct advantage over the PCR method for analysis of single cells. An improved spreading method for embryonic cells (Coonen et al., 1994b) , combined with the use of directly labelled DNA probes in a short hybridization procedure 1996a,b; Harper et al., 1994a Harper et al., ,b, 1995a , have made the FISH technique an efficient, fast and easy-to-perform procedure for preimplantation diagnosis of chromosomal disease. An alternative to the 'standard' ISH procedure might be the application of the primed in-situ labelling (PRINS) method, using chromosome-specific oligonucleotide primers (Pellestor et al., 1996a,b) . The FISH method has been proven to be especially valuable in determining the sex of embryos in cases of PGD for X-linked diseases (Coonen et al., 1996a,b; Harper, 1996 and references cited therein; Staessen et al., 1996; Delhanty et al., 1997) . Recently, the FISH technique has been used to detect (partial) aneuploidy in pre-implantation embryos due to parental translocations (Conn et al., 1996) . Sequential PCR and FISH analysis on single cells (cell recycling) allows the detection of specific chromosomes and specific gene sequences in the same embryonic cell (Thornhill et al., 1994; Thornhill and Monk 1996; Rechitsky et al., 1996b , Sasabe et al., 1996 Smith et al., 1997) .
Methods
Spreading and pre-treatment of embryonic cells
Whole embryos or single blastomeres need to be pretreated in order to achieve successful hybridization. Until recently, Tarkowski's method (1966) was the one most frequently used for spreading of whole embryos or single blastomeres. It involves cell fixation with methanol/acetic acid (3:1) often preceded by a hypotonic swelling step. However, the application of this method for preparation of human blastomeres has some drawbacks. The procedure suffers from frequent loss of cells due to the critical timing of the subsequent fixation steps and loss of cell morphology, resulting in nuclei which are useless for evaluation (Griffin et al., 1992) . These factors greatly decrease the reliability and reproducibility of this method. In the case of PGD, where the availability of material is usually limited to one or two blastomeres, this is obviously a great disadvantage. We have described a novel method to prepare single embryonic interphase nuclei, offering a high reproducibility, a good morphology of embryonic nuclei and a high hybridization efficiency (Coonen et al., 1994b) . This improved cell spreading method is based on the disaggregation of whole embryos or single blastomeres in a solution containing 0.01 N HCl/0.1% Tween-20. Initial studies have revealed that this method, in combination with the use of probes specific for repeated sequences, is a sensitive and reliable procedure that can be used for sex and ploidy determination of blastomeres in PGD (Coonen et al., , 1996a Harper et al., 1994a Harper et al., ,b, 1995a Staessen et al., 1996) .
Methodological aspects of ISH techniques
The ISH technique can be used to visualize specific DNA sequences, both in metaphase chromosomes and in interphase nuclei. Metaphase chromosomes can only be ob-tained after culture and subsequent mitotic arrest of cells and is, because of time pressure, not suitable for use in PGD. Chromosomes in interphase nuclei are generally organized in distinct domains so that their location, number and integrity can be assessed using (F)ISH with DNA probes specifically recognizing the involved chromosomes or parts thereof. This enables detection of numerical as well as structural aberrations. It may be clear that the clinical utility of FISH in PGD strongly depends on the availability and quality of probes that bind specifically to regions of genetic interest.
DNA probes
The DNA probes currently in use can be divided into three general categories.
The first group consists of probes specific for repeated DNA sequences, found primarily in the centromeric region of only one pair of chromosomes. The major application of such probes is in chromosome enumeration. Most studies to date on interphase embryonic cells have been accomplished using chromosome-specific probes that recognize repeated (centromeric) sequences, to determine the sex and or ploidy status of human blastomeres. When using centromere-specific DNA probes to study interphase nuclei, the number of chromosomes present is inferred from the number of hybridization signals observed. (F)ISH with probes, specific for repeated DNA sequences, does not allow for the analysis of structural aberrations in interphase nuclei, unless the aberrations happen to involve the repeated unit of the affected chromosome(s). This might be the case in Robertsonian translocations.
The second category is made up by chromosome subregion-specific probes (i.e. yeast artificial chromosomes (YAC); bacterial artificial chromosomes (BAC); cosmid contigs) and whole chromosome probes, made from chromosome-specific recombinant DNA libraries. Such painting probes are mixtures of DNA probes that have homology at multiple contiguous sites along the target chromosome. As chromosomes are thought to occupy domains in an interphase nucleus, the presence of a chromosome after FISH with whole chromosome probes will be indicated by a relatively large fluorescent area. Whole chromosome probes are useful for analysis of both structural and numerical aberrations in metaphase chromosomes, but are less applicable to study interphase cells. Although they enable detection of numerical aberrations and major translocations in (near) diploid cells, the applications in/for the analysis of human embryos are limited. This applies in particular to embryos that showed more than two pronuclei 16-18 h after fertilization, because their blastomeres are known to be genomically heterogeneous (Figure 1A ,B) and often contain many copies of a certain chromosome, resulting in the formation of multiple, possibly overlapping, domains. However, DNA probes specific for chromosomal subregions might be useful for the analysis of structural aberrations in human blastomeres (Coonen et al., 1994c) .
The third category of DNA probes comprises those homologous to unique DNA sequences, recognizing particular loci. Probes flanking or spanning a chromosomal breakpoint may be used to diagnose specific genetic diseases or previously identified chromosomal re-arrangements in human blastomeres (Coonen et al., 1994c) .
One of the latest developments is the use of synthetic oligonucleotide analogues called peptide nucleic acids (PNA) (Egholm et al., 1993) as probes for hybridization studies. Their unique properties allow a dramatic reduction in hybridization time and the use of highly stringent washing conditions. Preliminary studies on human pre-implantation embryonic nuclei indicate that PNA (kindly provided by DAKO A/S, Glostrup, Denmark) can be efficiently applied to this type of material for genetic analysis (E.Coonen, unpublished observations).
To accomplish a dependable FISH analysis, it is necessary to thoroughly investigate the characteristics (efficiency, signal appearance, polymorphism) of each probe before applying it in a clinical PGD setting.
Labelling of DNA probes
Visualization of DNA-DNA hybrids is achieved by chemical modification of the probe DNA. Initial ISH studies were based on radioactively-labelled probes and subsequent detection of hybrids by autoradiography (Gall and Pardue, 1969; John et al., 1969) . This isotopic approach was first described for sexing of human embryos by Jones et al. (1987) and West et al. (1987 West et al. ( , 1988 who used a radioactively labelled probe, specific for the Y chromosome. To overcome the main disadvantages of the autoradiographic method (hazardous, low spatial resolution and time-consuming), biotinylated probes that could be enzymatically detected were introduced. Although safer and quicker, enzymatic hybrid detection offered less spatial resolution. Application of this non-isotopic probe labelling for the ISH sex analysis of human embryos was reported by Penketh et al. (1989) . Fluorescence visualization of DNA-DNA hybrids combines the advantages of both previous methods (Manuelidis et al., 1982) , i.e. non-hazardous, relatively quick and offering a good spatial resolution. In 1990, the first reports appeared on the use of FISH to analyse human blastomeres (Grifo et al., 1990; Pieters et al., 1990) . In recent years, the application of directly labelled DNA probes for sex determination and/or assessment of ploidy Nuclei of two-pronuclear (2PN) embryos hybridized with a probe cocktail, consisting of a unique cosmid probe specific for chromosome 11q (small red signal), a repetitive probe specific for the centromeric region of chromosome 11 (large red signal) and a region specific YAC for chromosome 3q (green signal). (A) Normal, diploid nucleus; (B) aberrant, triploid nucleus. (C-E) MII oocytes and corresponding first polar body hybridized with a probe cocktail consisting of repetitive probes for the centromeric regions of chromosomes 1 (orange), 7 (red) and X (green). (C) Normal, haploid metaphase II chromosomes; (D) corresponding normal, haploid first polar body; (E) aberrant first polar body, showing disomy for chromosome X. (F-H) Nuclei of 2PN embryos hybridized with a probe cocktail, consisting of a unique cosmid probe specific for chromosome 11p (blue signal), a repetitive probe specific for the centromeric region of chromosome 11 (green signal) and a unique cosmid probe specific for chromosome 11q (red signal). (F) Normal, diploid nucleus; (G) aberrant, tetraploid nucleus; (H) aberrant nucleus, showing monosomy for the chromosome 11 centromeric region.
of human blastomeres has been described by various authors. The use of directly labelled probes eliminates the need for immunocytochemical detection of the formed hybrids, thereby reducing the time required for analysis. In general, fluorescence detection of DNA-DNA hybrids is preferred over enzymatic visualization because of the better spatial resolution of the former, the ability to quantitate fluorescence signals by photon counting and a greater potential for simultaneous multi-probe analysis. The number of different DNA regions that can be investigated simultaneously in an ISH reaction depends on the possibility of modifying the required DNA probes in such a way that they can be unequivocally distinguished from one another after visualization. Biotin and digoxygenin labelling of probes, combined with fluorescence detection, is currently the most widely used procedure for indirect visualization of DNA-DNA hybrids. The DNA sequence(s) of interest can also be directly visualized, using DNA probes that have incorporated a fluorochrome during chemical modification. In addition, DNA probes can be modified with combinations of different (in)direct labels, thereby increasing up to 12 the number of DNA targets that can be examined simultaneously and in the same preparation (Dauwerse et al., 1992) . Multiple target (more than three) FISH analysis in human blastomeres or embryos has its limitations, due to the enormous variety in genomic constitution that is encountered in this specific type of material. Moreover, reliable interpretation of results obtained with multiple target analysis is only possible using digital imaging devices such as CCD (charge-coupled device) cameras. The number of different chromosomes analysed within the same cell can also be increased by performing sequential FISH procedures. Although the fluorescence approach is mostly used, enzymatic hybrid detection results in non-fading, permanent hybridization signals that can be analysed in a routine setting with bright-field microscopy. Moreover, recent improvements in retaining the discreteness of hybridization signals, and the development of double and triple target ISH based on stable enzyme-substrate precipitates, offer new perspectives for multiple target ISH analyses and for the combination of ISH and the immunocytochemical detection of relevant antigens .
Hybridization procedure
PGD of genetic disorders is based on the analysis of small cell numbers and requires sensitive tests. Therefore, the efficiency of obtaining blastomeres in optimal condition for ISH analyis, as well as the ISH procedure itself, must be very high. Hybridization conditions should be carefully chosen and controlled, to prevent interaction of probes with DNA regions other than the target sequences. Most centromeric DNA probes available are highly specific and do not require extensive precautions to prevent cross-hybridization. Chances of cross-hybridization rise with increasing probe length, because of interspersed repetitive sequences, which are shared by other chromosomes. To achieve the desired staining contrast, these repeated sequences are blocked by adding unlabelled DNA (human genomic DNA, Cot I DNA) to the probe mixture.
Pitfalls in the interpretation of FISH signals on embryonic nuclei
The evaluation of FISH results in single embryonic nuclei requires strict criteria, as the reference population (remainder of the nuclei available for analysis) is very small or not even available for analysis in the case of a subsequent embryo transfer. An additional drawback in the analysis of nuclei from preimplantation embryos is the fact that internal standards are absent, since the genomic constitution of the various cells within one embryo is not known at the time of analysis. Especially in the case of polypronucleate embryos, where abnormal chromosome copy numbers and/or chromosomal mosaicism are to be expected , interpretation of the FISH data needs to be performed with great care. Also Lomax et al. (1994) have shown that the occurrence of numerical aberrations and/or mosaic chromosome patterns is an important confounder in the analysis of FISH data.
Efficient hybridization should result in a number of signals as expected on the basis of the number of pronuclei seen after fertilization. It is known, however, that asynchronous or delayed pronuclear formation occurs in 25% of embryos, initially classified as monopronucleate (Staessen et al., 1993) . Moreover, vacuoles are occasionally misidentified as pronuclei (Van Blerkom et al., 1987) . Recently, Levron et al. (1995) reported on the association of male and female gamete nuclei during the course of their interaction, through which a diploid, monopronucleate zygote is formed. It is therefore not always reliable to deduce chromosomal ploidy from the number of pronuclei present.
Various factors may influence the ISH pattern and the subsequent interpretation of the signals. The number of hybridization signals can be underestimated as a result of signal fusion, caused by co-localization of homologous DNA sequences in interphase nuclei (Matsumura et al., 1992) , or by signal overlap. Even though occurring at low frequency, attention should in this respect be paid to possible differences in size and intensity of the signals specific for the same probe within a nucleus. Apparent over-representation of chromosomes may be erroneously concluded from the occurrence of so-called 'split-spots'. These are separated, but closely linked signals on both chromatids, located in the centromeric region of a chromosome (Cremer et al., 1988; Hopman et al., 1988) . Again, signal size and localization may indicate this phenomenon. When using cosmid probes, the presence of 'doublets', duplicated signals as a result of DNA replication during the cell cycle, could further complicate the interpretation of the signal copy number (Matsumura et al., 1992; Selig et al., 1992) . FISH studies on human lymphocytes have shown that the percentage of apparently monosomic cells in normal individuals ranges from 5 to 10%, whereas the frequency of apparently trisomic cells is <1% (Eastmond and Pinkel, 1991) . It is therefore unlikely that the presence of supernumerical signals is due to FISH artefacts, provided that the quality of the FISH is high. Extrapolation of these data to embryonic cells would establish a low limit for the detection of trisomy or triploidy in these cells. Detection of loss of DNA material from human blastomeres, indicated by the loss of hybridization signals, is somewhat more complicated but is unlikely to be due to improper hybridization, given a high hybridization efficiency of the embryonic nuclei and a low percentage of aberrant (diploid) control cells, . Nevertheless, apparent monosomy due to inefficient hybridization can never be totally precluded, although the simultaneous application of multiple probes will drastically decrease the chance of an incorrect interpretation of the data.
Genomic constitution of human preimplantation embryos
It is obvious that extensive knowledge of the genomic constitution of human gametes and preimplantation embryos is a prerequisite for a reliable diagnosis. Initially, most studies on human gametes and embryos were performed by karyotyping (Angell et al., 1983 Mettler and Michelmann, 1985; Michelmann et al., 1986; Kola et al., 1987; Plachot et al., 1987 Plachot et al., , 1989 Plachot et al., , 1992 Wramsby et al., 1987; Angell, 1988; Macas et al., 1988 Macas et al., , 1990 Wimmers and van der Merwe, 1988; Papadopoulos et al., 1989; Ma et al., 1990 Ma et al., , 1995 Bongso et al., 1991b; Martin-Pont et al., 1991; Pellestor, 1991; Selva et al., 1991; Edirisinghe et al., 1992; Gras et al., 1992; Pieters et al., 1992; Balakier et al.,1993; Jamieson et al., 1994) . As mentioned above, PCR and (F)ISH techniques were applied in ensuing years. Although information on the genomic constitution of human gametes and embryos obtained by (F)ISH is accumulating rapidly, it cannot be discussed without relating it to the knowledge derived from other techniques.
Are analysed blastomeres representative of the whole embryo?
The most crucial assumption in PGD is that the blastomere(s) removed from the embryo for analysis may be regarded as truly representative of the whole embryo. It is therefore of the utmost importance to perform (extensive) feasibility studies to collect information on the genomic constitution of all cells present in one and the same embryo. In view of this principle, information obtained from a few blastomeres, analysed as part of PGD followed by embryo transfer, hardly contributes to our knowledge. Although a second analysis at a later stage (e.g. prenatal diagnosis) can confirm the result of the PGD, and an ongoing pregnancy reflects the embryo's developmental capacity, the embryonic material analysed at this later stage may no longer fully represent the genetic constitution of the preimplantation embryo, nor does prenatal diagnosis shed any light on the possible selection mechanisms that take place during early embryonic development. To date, most FISH studies have focused on the examination of polar bodies or day 3 (4-8-cell) human embryos, as the embryo biopsy is usually performed at this time and it is important to ascertain the incidence of chromosomal abnormalities at these particular embryonic stages. However, FISH data obtained from day 2 (2-4-cell) embryos could provide more insight into the earliest developmental (genetic) processes and would fill the gap between FISH data obtained from day 3 embryos and karyotyping data obtained from (un)fertilized oocytes.
The need for analysis of all blastomeres from one embryo to warrant a complete understanding of early developmental processes imposes upon the procedures for embryo spreading and hybridization. We have shown that embryo spreading with 0.01 N HCl/0.1% Tween-20 (Coonen et al., 1994b) in combination with FISH using (directly labelled) DNA probes is a very efficient approach 1996a,b; Harper et al., 1994 Harper et al., , 1995a Staessen et al., 1996) and is sensitive enough to permit the detection of unique DNA sequences in embryonic nuclei (Coonen et al., 1994c) .
External factors that may cause genomic instability of blastomeres
Embryos used for research analysis are usually aberrant in the sense that they exhibit morphological abnormalities and/or display retardation in cleavage after fertilization. Studies on the morphology of human embryos in relation to their genomic constitution have shown that the rate of chromosomal anomalies detected is strongly correlated to the morphological aspect of the embryos (Plachot et al., 1988; Munné et al., 1994a; Pellestor et al., 1994a,b) . Fur-thermore, studies by Munné et al. (1993a Munné et al. ( , 1994b Munné et al. ( , 1995a indicate that there may well exist a relationship between certain chromosomal anomalies and aberrant embryonic development.
Additional factors contributing to the high percentages of chromosomal aberrations found in preimplantation embryos by means of FISH may result from the fact that most embryos used for research purposes are donated by patients undergoing IVF or ICSI for infertility treatment. The high degree of aneuploidy and mosaicism may well reflect artefacts caused by drug-induced ovulation, assisted reproduction techniques and/or in-vitro embryo culture. Moreover, the infertility patients' average age is well advanced when compared to the maternal age in the general population. Although there is no consistency in data available from the literature concerning chromosomal abnormalities in relation to maternal age (reviewed by Zenzes and Casper, 1992; Angell et al., 1993; Munné et al., 1995a; Benadiva et al., 1996; Benkhalifa et al., 1996; Dailey et al., 1996; Wall et al., 1996) , a number of studies support the hypothesis that aneuploidy shows an increased incidence in oocytes of older women.
Transfer and/or cryopreservation of the best embryos obtained after IVF implies that only 'second best' embryos can be used for research. It is as yet not known whether current data on human preimplantation embryos are biased accordingly, but the possibility should be kept in mind.
Chromosomal mosaicism in human preimplantation embryos
The majority of data available on chromosomal mosaicism and aneuploidy in preimplantation embryos is derived from karyotyping studies of oocytes and preimplantation embryos. However, the quality of chromosomes obtained from embryonic cells is usually very poor and chromosome plates are seldomly obtained from more than a few cells per embryo. The incomplete data obtained by karyotyping can therefore not be used as a standard for comparison with the data obtained by ISH. Although information provided by karyotyping studies is fragmentary as far as the number of cells investigated is considered, it does give a detailed view of the chromosomal constitution of those blastomeres that could be successfully analysed. From these studies it has become clear that nuclei of preimplantation embryos, arising from tripronuclear zygotes, display a variety of chromosomal complements (Angell et al., 1986; Michelmann et al., 1986; Kola et al., 1987; Plachot et al., 1989; Pieters et al., 1992) . They include (i) complete triploidy in all cells after regular division, (ii) gross abnormalities in all cells due to chaotic chromosome movement after multipolar spindle division, (iii) cell subpopulations with either a haploid or a diploid chromosomal content because of extrusion of a haploid nucleus during the first cleavage division, and (iv) cell subpopulations with a diploid or a triploid chromosomal content as a result of extrusion of a haploid nucleus during the first cleavage division and subsequent incorporation in one of the two nuclei. FISH studies performed on nuclei of embryos resulting from abnormal fertilization revealed mostly mosaic chromosome complements.
An ever-accumulating number of FISH studies is being published, in which virtually all cells from human preimplantation embryos are analysed. From the studies to date it has become clear that chromosomal mosaicism and aneuploidy are common features of embryos resulting from both abnormal Harper et al., 1994) as well as normal Munné et al., 1993a Munné et al., ,b, 1994b Munné et al., ,c, 1995c Harper et al., 1994a Harper et al., , 1995 Coonen et al., 1996a,b; Delhanty et al., 1997) fertilization. Chromosomal mosaicism and/or aneuploidy have been detected both for sex chromosomes (Griffin et al., 1991; Jakobsson et al., 1995; Laverge et al., 1997) as well as for autosomes (Schrurs et al., 1993; Bergere et al., 1995a) . The degree and type of mosaicism and/or aneuploidy detected seem to be related to a number of parameters, including maternal age, (ab)normal fertilization, embryo development, embryo morphology, presence of anucleated/ multinucleated blastomeres and number and type of simultaneously detected chromosomes. Also culture conditions and/or stimulation protocols may play a role (Munné et al., 1997) . Studies performed on two-pronuclear (2PN) embryos for research purposes indicate that the level of mosaicism detected is high, ranging from 43% (autosomes 1 and 7) in 2PN embryos of good morphology (Harper et al., 1995) to 70% (sex chromosomes and autosomes 13/21 and 18) in abnormally developing monospermic embryos (Munne et al., 1993a) . Also during preimplantation sex determination, chromosomal mosaicism and aneuploidy as revealed by FISH have been detected Griffin et al., 1994; Coonen et al., 1996a,b; Staessen et al., 1996) , and the majority of abnormalities found in the analysed blastomeres was confirmed by analysis of the remainder of the embryo. Notwithstanding the fact that chromosomal mosaicism for the sex chromosomes has been demonstrated in embryos resulting from normal fertilization, as yet no reports are known about the presence of a 'normal' female (XX) nucleus in an otherwise uniformly 'normal' male (XY) embryo, which could lead to a preimplantation misdiagnosis of sex. FISH analyses have revealed four distinct groups of chromosome patterns in human preimplantation embryos, namely a normal pattern, a pattern showing a single chromosome abnormality, mosaic patterns and chaotic patterns .
An assay to detect chromosomal mosaicism as a decisive parameter for embryo transfer is only relevant for embryos resulting from normal fertilization (2PN). The detection of (a relatively high degree of) mosaicism in such embryos causes great concern and for that reason it is recommended to use two blastomeres (if available) for PGD of chromosomal abnormalities or dominant disorders. For recessive disorders, false positive or negative results due to ADO may be prevented by biopsy of two blastomeres. When results from both cells are conflicting, the embryo should not be considered suitable for transfer. However, it should be kept in mind that although the analysis of one or two blastomeres of the embryo under consideration for transfer may not reveal any mosaicism, chromosomal heterogeneity among the remaining cells can never be totally excluded.
The incidence of chromosomal anomalies in spontaneous abortions or live births after IVF is not as high as would be expected on the basis of the incidence of chromosomal abnormalities in (IVF) preimplantation embryos. There are several explanations for this phenomenon. First, chromosomal aberrations could lead to a failure of the embryo to implant, thus not leading to a viable pregnancy. Second, chromosomal aberrations that do not affect the preimplantation embryo could be lethal in early postimplantation developmental stages. Third, if few chromosomally abnormal cells are present in an otherwise normal embryo, they may develop at a slower rate than the normal cells or may be even excluded from further cell division in later embryonic development. Finally, selection mechanisms could occur to influence the fate of embryonic cells upon partition of the inner cell mass and the embryo proper during blastocyst formation (James and West., 1994) .
Anucleate and multinucleate blastomeres in preimplantation embryos
Apart from the occurrence of chromosomal mosaicism in human preimplantation embryos, the presence of multinucleated or anucleated blastomeres could hamper a reliable PGD based on FISH. Blastomeres with an abnormal number of nuclei are readily found in preimplantation embryos. About 17% of all 2-4-cell embryos resulting from normal fertilization contain at least one binucleate blastomere, increasing to 65% at the 9-16-cell stage (Hardy et al., 1993) . Cytometric measurement of the cellular DNA content of multinucleated human blastomeres revealed that they contain total DNA levels consistent with a diploid DNA content . Munné and Cohen (1993) reported the presence of multinucleated human blastomeres in about one-third of human embryos that showed arrested cleavage. FISH analysis of these blastomeres revealed that in 95% of the embryos in which multinucleated blastomeres were analysed, these blastomeres were of the same sex as the entire embryo, but that the total number of sex chromosomes per multinucleated blastomere and their distribution among the different nuclei varied greatly. Hence, these blastomeres were regarded unsuitable for PGD at the preimplantation stage. The observation that multinucleated blastomeres often contain chromosomal abnormalities was confirmed by Kligman et al. (1996) . The incidence of anucleate blastomeres in embryos resulting from normal fertilization has also been reported to be high, especially in embryos of poor morphology (Hardy et al., 1993) . Pickering et al. (1995) reported that 24% of dividing mononucleated blastomeres, cultured individually after disaggregation of day 2 or day 3 embryos, formed one or more abnormally nucleated daughter blastomeres. About one-third of the anucleated and one-third of the multinucleated blastomeres continued cleaving, forming mostly abnormally nucleated daughter blastomeres. If an anucleate blastomere is removed from the embryo for PGD analysis, no information will be obtained on the genomic constitution of the embryo and another blastomere will need to be removed and subsequently analysed. It is therefore important to have a mononucleated cell available for analysis. The spreading method using HCl/Tween-20, developed for embryonic nuclei to be analysed by FISH (Coonen et al., 1994b) , allows a continuous survey of the biopsied blastomere and provides certainty about the presence and number of nuclei. Furthermore, Cui and Matthews (1996) argued that for PCR analysis the nuclear morphology of biopsied cells should be optimal, in order to ensure a reliable and efficient diagnosis.
FISH analysis of ICSI failures
Assisted fertilization protocols, for instance the intracytoplasmic sperm injection (ICSI) procedure, have been introduced to help couples for whom standard IVF treatment fails due to severe male factor infertility (Palermo et al., 1992) . The ICSI method is a microinjection procedure during which a single spermatozoon is injected in the cytoplasm of an oocyte. Apart from the advantage that with the ICSI method only one spermatozoon per oocyte is needed for fertilization, it also ensures monospermic fertilization of each oocyte. In 55% of all oocytes fertilized by ICSI, two pronuclei are detected, and most of the embryos arising therefrom show normal cleavage and morphology (Van Steirteghem et al., 1994) . However, a small percentage of the oocytes shows either only one pronucleus (1PN) or does not undergo cleavage at all (Van Steirteghem et al., 1994) . Since these embryos are not eligible for transfer or cryopreservation, they may become available for research purposes. It would be of interest to know whether these apparent monopronucleate embryos and non-dividing oocytes have indeed been fertilized and/or if their genomic constitution shows abnormalities. The application of the FISH technique to analyse these so-called ICSI failures provides certainty about fertilization by the identification of a Y chromosome, or yield information on the ploidy status of the embryo. Based on a general DNA staining, Flaherty et al. (1995) reported that 83% of 1PN embryos after ICSI are not activated, although in 66% of these embryos a swollen sperm head was detected. However, Bergere et al. (1995b) found non-decondensation of the injected spermatozoon to be the major course for 1PN embryo formation. Staessen et al. (1997) concluded from FISH studies that 28% of 1PN ICSI embryos show a diploid chromosome complement and that 31% are haploid. Others have found that parthenogenetic activation is the major course for the formation of 1PN embryos after ICSI (Sultan et al., 1995) . In line with these findings, Macas et al. (1996) showed that in 82% of cases the haploid chromosome complement found in 1PN ICSI embryos is of maternal origin.
Another intriguing phenomenon is the fact that, after ICSI, a small proportion of oocytes shows three (3PN) or even more pronuclei (Van Steirteghem et al., 1994) . As the ICSI procedure eliminates the possibility of 3PN oocytes as a result of diandry, this implies either digyny after nonextrusion of the second polar body or (less probable) injection of a diploid spermatozoon. FISH on 3PN oocytes after ICSI, using probes for both sex chromosomes, should reveal whether digyny indeed accounts for the majority of the additional pronuclei seen. Flaherty et al. (1995) reprorted that -based on observations after DNA staining -the major course for formation of a 3PN embryo after ICSI is retention of the second polar body. FISH studies on 3PN ICSI embryos confirmed the digynic origin of this phenomenon (Staessen et al., 1997) .
Prospects for ISH study of human (preimplantation) embryos
Structural aberrations
So far, most ISH studies involving human embryos have concentrated on the detection of numerical chromosome aberrations. However, initial studies have demonstrated that the detection of unique, non-repetitive sequences in embryonic cells is also feasible (Coonen et al., 1994c) ( Figure 1F-H) . Nevertheless, a drastic increase in ISH sensitivity is still needed to permit reliable detection of structural errors on a single cell basis. If sufficient sensitivity can be achieved, PGD of structural genomic abnormalities with a high recurrence risk, such as the Robertsonian translocations, may be within reach. However, the structural aberration under investigation will usually represent a unique chromosomal rearrangement. Therefore, we expect that the procedures for the detection of these rearrangements at a preimplantation stage in single blastomeres will have to be tailored for each specific diagnostic problem. In this respect, the development of a general approach, applicable to each or most of the individual cases, would greatly improve the introduction of this type of analysis in 'routine' PGD. Recently, the first PGD cycles for translocations were reported by Conn et al. (1996) . Munné et al. (1995b) showed that, when retrieved within a time course of 6 h, first polar bodies are suitable for PGD of maternally inherited aneuploidy. We have suggested that the DNA of these first polar bodies exhibits several levels of condensation, ranging from separate chromosome-like structures to an interphase-like organization (Coonen et al., 1996c) (Figure 1C-E) . The transition from one form into the other might well be time-related (E.Coonen, unpublished observations). If preparation of polar bodies could be optimized in such a way that a chromosome-like configuration of their DNA is available, PGD using painting probes should allow detection of structural aberrations. This then provides a general approach to detect maternally inherited structural aberrations at a preconception stage.
Combination of genotypic and phenotypic analyses
One of the merits of the (F)ISH technique is that it can be simultaneously applied to the same preparation with other cytochemical assays used for phenotype analysis . This combination of methods allows direct correlation between genetic aberrations identified by FISH, and specific phenotypic characteristics, such as those indicating cell type or cell cycle stage. For example, FISH on human morulae and blastocysts revealed that they contain (abnormal) polyploid cells (Benkhalifa et al., 1993) . Although Mottla et al. (1995) demonstrated that blastomeres of early cleavage stage embryos contribute to both trophectoderm and inner cell mass, others formulated a hypothesis that the genomically aberrant cells, formed in the course of early embryogenesis, are diverted to form the trophectoderm during blastocyst formation, and as a consequence do not take part in the formation of the embryo proper (James and West, 1994) . This phenomenon might be the underlying cause of confined placental mosaicism (Kalousek et al., 1996; Wolstenholme, 1996) . A combination of FISH, to supply information on the genetic status of the embryonic cell, and immunocytochemistry, using a marker to discriminate between inner cell mass and trophectoderm, may provide supporting or excluding evidence in this matter.
Comparative genomic hybridization (CGH)
The CGH method represents a fairly new approach for the global screening of genetic imbalances in test material (Kallioniemi et al., , 1994 duManoir et al., 1993) . The analysis is based on the relative FISH signal intensity of test DNA as compared to normal total DNA. The relative copy number of homologous sequences is directly reflected by the ratio of the different fluorescence intensities after ISH of a 1:1 mixture of test and normal DNA to normal human metaphases. Speicher et al. (1993) first reported on the application of CGH in cancer studies using genomic tumour cell DNA amplified by degenerate oligonucleotide primed PCR (DOP-PCR), hence making the amount of test material available no longer an important limiting factor. Using this approach successful CGH was achieved with an initial amount of 50 pg of genomic DNA. Given that the genomic content of one single human cell is 7 pg, Speicher et al. (1993) stated that ten cells would suffice to perform CGH after DOP-PCR-mediated DNA amplification. However, it has to be kept in mind that a considerable amount of DNA is lost during isolation. It is therefore most probable that more cells are needed to yield 50 pg of total genomic DNA. An alternative would be to perform DOP-PCR directly on intact cells, thereby circumventing the necessity to isolate DNA prior to amplification. If these sensitivity problems can be solved, CGH could be applied to human embryos for PGD. There are, however a number of drawbacks. At present, CGH allows detection of deletions and amplifications of 1-10 Mb, whereas the detection limit for amplified genomic sequences can be even lower, i.e. 100 kb, provided that the amplicon is repeated at least 20 times . Unfortunately, the CGH method cannot reveal translocations, inversions or other aberrations that do not change the copy number of DNA sequences, nor does it provide information on the exact ploidy status of the test material used. Furthermore, aberrations involving repeated sequences, e.g. those occurring in the centromeric and telomeric regions, are not reliably detectable because of the DNA suppression principle. Another major problem is that with CGH, only aberrations that are present in a substantial proportion of the cells tested (at least 50%) are detectable. This makes the CGH method an inadequate tool for detection of chromosomal mosaicism in human preimplantation embryos since the simultaneous amplification of DNA from genomically distinct cells with DOP-PCR will level out the differences in chromosomal constitution of the individual blastomeres. Although we feel that the CGH method is at present not suitable for preimplantation analysis, it could serve as a powerful method for the study of human abortion material. Karyotyping of such specimens is often hampered by low mitotic indices, and the necessity to culture cells may hamper the visualization of crucial aberrations due to selective growth of certain cell populations. Recently, several studies were published performing FISH on sections of paraffin embedded embryonic material with DNA probes specific for repetitive centromeric sequences to retrospectively determine the embryos genomic constitution (Mori and Shiota, 1994; Nakamura et al., 1994; Van Lijnschoten et al., 1994) . If sufficient DNA can be extracted from archival abortion material, and subsequently be amplified by DOP-PCR, retrospective CGH analyses become feasible.
Analysis of spermatozoa
PGD carried out on embryos is restricted by the small amount of material, but offers the chance of assaying DNA from cells that are fully representative of the embryonic genome. Spermatozoa, however, are in most cases readily available but their DNA represents only half the genome of a potential embryo.
One advantage of analysing spermatozoa for PGD lies in the possibility of averting the birth of males with sexlinked disorders by identifying and separating X-and Ybearing spermatozoa as a means of controlling the sex ratio. Numerous attempts have been made to implement such an approach in a clinical setting (Wang et al., 1994 and references cited therein).
At present, genomic analysis of spermatozoa by means of (F)ISH is not possible without destroying their viability. Nevertheless the method can be very helpful in assessing the success rate of different separation protocols or to make a general inventory of the genomic numerical changes occurring in spermatozoa (aneuploidy, non-disjunction). The latter could be valuable for PGD by identifying individuals that are predisposed to increased rates of genomic alterations. The (F)ISH analysis of spermatozoa is hampered by the fact that the DNA in the sperm head is condensed and difficult to access. An efficient decondensation to improve the accessibility of the DNA is therefore an essential step for successful hybridization. DNA decondensation is, however, often achieved at the expense of sperm morphology, making the interpretation of the (F)ISH results rather complex. Moreover, most spermatozoa loses the tail during pre-treatment procedures and thus become hardly distinguishable from somatic cells in the ejaculate.
Many studies have reported on the use of (F)ISH in human spermatozoa in order to determine the incidence of aneuploidy for particular chromosomes (Joseph et al., 1984; Guttenbach et al., 1990 Guttenbach et al., , 1991 Guttenbach et al., , 1994 Pieters et al., 1990; Wyrobek et al., 1990 Wyrobek et al., , 1992 Coonen et al., 1991; Han et al., 1992 Han et al., , 1993 Holmes et al., 1993; Martin et al., 1993; Robbins et al., 1993; Bischoff et al., 1994; Martini et al., 1994; Miharu et al., 1994; Rademaker et al., 1997) . The results of these studies lack, general consensus with respect to the percentages of such numerical chromosome aberrations in spermatozoa, possibly due to the varying evaluation criteria. Recently, Martini et al. (1995) described a new approach for ISH in spermatozoa, making use of permanent enzyme-substrate precipitates to visualize the ISH signals combined with a morphological staining to outline the whole spermatozoon, including the tail. By such means, it is possible to discriminate between disomic, diploid and abnormal spermatozoa and to recognize somatic cells present in the ejaculate, hence making an accurate estimation of chromosomal aneuploidy in spermatozoa possible.
Karyotyping studies have revealed that structural aberrations are also present in spermatozoa of normal, healthy men (reviewed by Pellestor, 1991) . As the detection of structural aberrations in embryos is one of the future aims of human PGD, there is an obvious need for information regarding the presence of such anomalies in human gametes. PGD of structural abnormalities will be of benefit to couples in which one of the partners is the carrier of a balanced translocation. The likelihood of such a patient of producing abnormal offspring depends on both the proportion of chromosomally unbalanced gametes that is being produced and the phenotypic effects of this particular imbalance upon the zygote Hultén, 1992, 1993) . General information on the latter is usually available from empirical data but details on the segregational properties and gamete output of translocations are more elusive. The FISH technique, using whole chromosome and paracentromeric DNA probes, has been used to study chiasma frequency and meiotic segregation in testicular material of male balanced translocation carriers Hultén, 1992, 1993) . From such data information can be derived on how combinations of normal, balanced and unbalanced gametes arise and changes on each possibility can be calculated. An alternative for the screening of spermatozoa for the presence of structural aberrations would be the application of (F)ISH using DNA probes specific for unique sequences, flanking or spanning the chromosomal breakpoints. We expect that proper pretreatment of the spermatozoa, combined with a sensitive hybridization method, will allow detection of structural abnormalities in these cells. Evaluation of spermatozoa, as part of a general protocol for detection of structural aberrations in PGD, would increase the reliability of the analysis.
